Briacell Therapeutics Corp BCTX

$3.16 -0.12 (-3.66%)

Valuation

Market cap
28,642,000
Revenue TTM
$0
Net income TTM
$-34,900,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
63,800
Avg volume
94,510
Day's range
$3.15 – $3.30
Shares out
8,732,000
Stochastic %K
1%
Beta
1.26
Analysts
—
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604-921-1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

Stocktwits

BCTX20bMC Nov 19, 11:28 PM
$BCTX a stranger’s comment on the internet is insulting to you? You are searching for attention…making moron 10-15% chances comments. There is a ton of info a 5 yr old can find here in 15 mins…or watch any of the numerous recent presentations. Bc you trolled…makes you a moron.
0 replies
AliceFireSteam Nov 19, 10:48 PM
$BCTX a reminder table for all
0 replies
PensiveInvestor Nov 19, 9:13 PM
$BCTX They doubled the survival to 16.6 months on patients who normally have survival between 6.7 to 9.8 months. The fact that the phase 2 consist of 54 patients, it is not impossible to assume that they can do it in the phase 3 with 177 patients. Also they don't need to double , they need to improve to 40% in interim analysis or 30% in final analysis. There is a chance, and the longer it takes , the better the odds, similar to $SLS.
1 replies
Kris600 Nov 19, 8:56 PM
$BCTX question to holders: why do you believe this company can succeed? Based on not impressive phase 2 results and statistics there is just 10-15% chance of success. I'm asking about facts, not wishful thinking. Thanks in advance.
3 replies
AliceFireSteam Nov 19, 8:30 PM
$BCTX if HR is between 0.6 and 0.7 at interim 1 the company is most likely to dilute to hell and back, as they would need 30M (at least) for another year of operations.
1 replies
PensiveInvestor Nov 19, 8:24 PM
$BCTX what will happen if hr is between 0.6 and 0.7 let's say 0.65? Will it tank or will it rise or will it stay the same?
1 replies
CoffeeRocks Nov 19, 5:40 PM
$BCTX 3$ 🔜
0 replies
jfun1 Nov 19, 1:03 PM
$BCTX phase 3 asset ridiculously priced under 30 million. I said the same thing about $SLS now look
1 replies